Search

Your search keyword '"Paknis, Brandee"' showing total 21 results
Start Over Author "Paknis, Brandee"
21 results on '"Paknis, Brandee"'

5. Proceedings of the 2017 WAO Symposium on Hot Topics in Allergy: Pediatric & Regulatory Aspects: Rome, Italy/Vatican City. 27-29 April 2017

Author

Traina, Giovanni, Valluzzi, Rocco Luigi, Fierro, Vincenzo, Riccardi, Carla, Artesani, Maria Cristina, De Vuono, Andrea, Fiocchi, Alessandro, Martelli, Alberto G, Ríos, Luis Alberto, Alcocer, Christian R, Navarrete, Elsy, Del Rio Navarro, Blanca Estela, Gonzalez, Victor, Velasco, Berenice, Perez Aviles, Herberth J, Fernandez, Roberto Jose, Pozo, F Cesar, Farhan, Abdal Jabbar, Arshad, Hasan, Hussain, Ahmed, Sharikadze, Olena, Okhotnikova, Olena, Alcover, Javier, Rodriguez, Diego, Pineda, Fernando, Dalal, Ilan, Weinbrand-Goichberg, Jenny, Benor, Shira, Rottem, Menachem, Kivity, Shmuel, Sato, Sakura, Yanagida, Noriyuki, Ebisawa, Motohiro, Umanets, Tetiana, Antipkin, Youriy, Barzylovich, Vladyslava, Lapshyn, Volodymyr, Umanets, Mykola, Yuriev, Sergey, Bekir, Suzan, Pincock, Tobias, Vieira Hernandez, Alberto, Capriles Hulett, Arnaldo, Sánchez Borges, Mario, Fabiano, Fabiola, Albarran, Carlos, Goyal, Rohit, Gupta, Shilpa, Gaurav, Garg, Luskin, Allan T, Griffin, Noelle M, Wagelie-Steffen, Amy, Trzaskoma, Benjamin L, Limb, Susan L, Busse, William W, Zeiger, Robert S, Gonzalez-Reyes, Erika, Casale, Thomas B, Chipps, Bradley E, Sugizaki, Chizuko, Goto, Fumiko, Yamaide, Akiko, Mitsunaga, Kanako, Tomiita, Minako, Hoshioka, Akira, Shimojo, Naoki, Pop, Liviu L, Ciucǎ, Ioana-Mihaela, Tǎmaş, Liviu, Lazarescu, Marilena, Pienar, Corina, Yamaide, Fumiya, Fikri, Bahrul, Sato, Hironori, Okishima, Naoko, Kobayashi, Miyabi, Takai, Mizuki, Nishigata, Kotarou, Yoda, Ryou, Oana, Yu-Ta, Kajiwara, Chifu, Shimodaira, Moe, Suzuki, Tomoka, Iizawa, Hiromi, Kamijo, Koji, Karmakar, Bijoya, Bhattacharya, Swati Gupta, Blohlávková, Simona, Kopelentová, Eliška, Víšek, Petr, Štádler, Jakub, Šetinová, Ivana, Novobílská, Jana, Lundelin, Krisa, Salminen, Seppo, Isolauri, Erika, Pitt, Tracy, Flanders, Tamar, Peñalver, Marcos, Martínez, Patricia, Lluch, Magdalena, Malet, Alfonso, Nam, Young-Hee, Jin, Hyun Jung, Lee, Soo-Keol, Kulalert, Prapasri, Sritipsukho, Paskorn, Pathumanond, Jayanton, Baynova, Krasimira, Labella, Marina, De Aramburu, Teresa, Prados, Manuel, Haanpää, Leena, Aarnio, Jasmin, Nermes, Merja, Af Ursin, Piia, Kaljonen, Anne, Bala, Nandana, Bhagwat, Ketaki, Hindley, James, Chapman, Martin, Baalasubramanian, Sivasankar, Besednjak-Kocijančič, Lilijana, SenGupta, Koyel, Antonova, Evgeniya, Kong, Amanda M, Iqbal, Ahmar, Teague, W Gerald, Trzaskoma, Benjamin, Ortiz, Benjamin, Paknis, Brandee, Iqbal, Amar, Rosen, Karin, Szefler, Stanley, Alblooshi, Afaf, Al-Hammadi, Suleiman, Vega, Arantza, Gutiérrez-Rivas, Raquel, Alonso, Ana Maria, Beitia, Juan Maria, Belén Mateo, Maria, Cárdenas, Remedios, García-Domínguez, Juan Jesús, Pitchon Dos Reis, Raquel, Gonçalves Alvim, Cristina, Andrade, Claudia, Reis, Adriana, Ribeiro, Henrique, Panaitescu Bunu, Carmen, Marusciac, Laura, Paralescu, Sorin, Tamas, Paul, Panitescu Bunu, Carmen, Martí Guadaño, Enrique, Escobar Bolaños, Carolina, Martí José, Natalia, Pau Casanovas, Pol, Biarnés Rib, Gemma, Castells, Mariana, de Vicente Jiménez, Talía, Mennini, Maurizio, De Angelis, Papola, Rea, Francesca, Malamisura, Monica, Tambucci, Renato, Dall'Oglio, Luigi, Del Chierico, Federica, Napolitano, Tania, Reddel, Silvia, Vernocchi, Pamela, D'Ambrosio, Angelo, Putignani, Lorenza, Dahdah, Lamia, Banzato, Claudia, Echeverría Zudaire, Luís Angel, Plaza, Ana María, Bosque García, Montserrat, Íbero, Marcel, Mazzina, Oscar, Marzano, Valeria, Pecora, Valeria, Koch, Pierluigi, Pecora, Valentina, Valentini, Diletta, Santamaria, Francesca, Valluzzi, Rocco, Mukherjee, Anwesha, Kandhare, Amit, and Bodhankar, Subhash

Published
2017

6. Perspectives on Living with Chronic Spontaneous Urticaria: From Onset through Diagnosis and Disease Management in the US.

Author

GOLDSTEIN, Stanley, EFTEKHARI, Sanaz, MITCHELL, Lynda, WINDERS, Tonya A., KAUFMAN, Leslie, DUDAS, Debra, PAKNIS, Brandee, KAVATI, Abhishek, DELWART, Virginie, and SOFEN, Howard L.

Subjects
URTICARIA, DISEASE management, DIAGNOSIS, MEDICAL personnel, THERAPEUTICS
Abstract

Chronic spontaneous urticaria is challenging to manage and substantially affects quality of life. This US, non-interventional qualitative study examined patients' clinical journeys and emotional burden from symptom onset through disease management. Chronic spontaneous urticaria patients participated in interviews and completed diaries focusing on disease and treatment history/perspectives, impact on personal/family life, and relationships with physicians/other healthcare providers. Physicians were interviewed about their views on disease management and patient care. Twenty-five patients, previously or currently receiving chronic spontaneous urticaria treatment(s), and 12 physicians participated. Key stages following symptom onset were identified: Crisis (associated with feelings of torment/disorientation/shock); Searching for answers (puzzlement/frustration/anxiety); Diagnosis (relief/satisfaction/fear/isolation); and Disease management (frustration/hope/powerlessness). Findings revealed patients' perceptions and experiences of chronic spontaneous urticaria, including living with a 'skinemy', experiencing their 'own personal hell' and feeling 'like an experiment'. Awareness of unmet needs in patient care/management identified in this study may ultimately improve patient support and enhance physicians' understanding of disease burden. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

8. More than a decade follow-up in patients with severe or difficult-to-treat asthma: The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) II

Author

Chipps, Bradley E., primary, Haselkorn, Tmirah, additional, Paknis, Brandee, additional, Ortiz, Benjamin, additional, Bleecker, Eugene R., additional, Kianifard, Farid, additional, Foreman, Aimee J., additional, Szefler, Stanley J., additional, and Zeiger, Robert S., additional

Published
2018
Full Text
View/download PDF

10. An Analysis of Type 2 Biomarkers in TENOR II

Author

Bleecker, Eugene R., primary, Szefler, Stanley J., additional, Zeiger, Robert S., additional, Foreman, Aimee, additional, Haselkorn, Tmirah, additional, Neiman, Evgueni, additional, Kianifard, Farid, additional, Paknis, Brandee, additional, Ortiz, Benjamin, additional, and Chipps, Bradley E., additional

Published
2018
Full Text
View/download PDF

18. Proceedings of the 2017 WAO Symposium on Hot Topics in Allergy: Pediatric & Regulatory Aspects

Author

Traina, Giovanni, Valluzzi, Rocco Luigi, Fierro, Vincenzo, Riccardi, Carla, Artesani, Maria Cristina, De Vuono, Andrea, Fiocchi, Alessandro, Martelli, Alberto G., Ríos, Luis Alberto, Alcocer, Christian R., Navarrete, Elsy, Del Rio Navarro, Blanca Estela, Gonzalez, Victor, Velasco, Berenice, Perez Aviles, Herberth J., Fernandez, Roberto Jose, Pozo, F. Cesar, Farhan, Abdal Jabbar, Arshad, Hasan, Hussain, Ahmed, Sharikadze, Olena, Okhotnikova, Olena, Alcover, Javier, Rodriguez, Diego, Pineda, Fernando, Dalal, Ilan, Weinbrand-Goichberg, Jenny, Benor, Shira, Rottem, Menachem, Kivity, Shmuel, Sato, Sakura, Yanagida, Noriyuki, Ebisawa, Motohiro, Umanets, Tetiana, Antipkin, Youriy, Barzylovich, Vladyslava, Lapshyn, Volodymyr, Umanets, Mykola, Yuriev, Sergey, Bekir, Suzan, Pincock, Tobias, Vieira Hernandez, Alberto, Capriles Hulett, Arnaldo, Sánchez Borges, Mario, Fabiano, Fabiola, Albarran, Carlos, Goyal, Rohit, Gupta, Shilpa, Gaurav, Garg, Luskin, Allan T., Griffin, Noelle M., Wagelie-Steffen, Amy, Trzaskoma, Benjamin L., Limb, Susan L., Busse, William W., Zeiger, Robert S., Gonzalez-Reyes, Erika, Casale, Thomas, Chipps, Bradley E., Sugizaki, Chizuko, Goto, Fumiko, Yamaide, Akiko, Mitsunaga, Kanako, Tomiita, Minako, Hoshioka, Akira, Shimojo, Naoki, Pop, Liviu L., Ciucǎ, Ioana-Mihaela, Tǎmaş, Liviu, Lazarescu, Marilena, Pienar, Corina, Yamaide, Fumiya, Fikri, Bahrul, Sato, Hironori, Okishima, Naoko, Kobayashi, Miyabi, Takai, Mizuki, Nishigata, Kotarou, Yoda, Ryou, Oana, Yu-ta, Kajiwara, Chifu, Shimodaira, Moe, Suzuki, Tomoka, Iizawa, Hiromi, Kamijo, Koji, Karmakar, Bijoya, Bhattacharya, Swati Gupta, Blohlávková, Simona, Kopelentová, Eliška, Víšek, Petr, Štádler, Jakub, Šetinová, Ivana, Novobílská, Jana, Lundelin, Krisa, Salminen, Seppo, Isolauri, Erika, Pitt, Tracy, Flanders, Tamar, Peñalver, Marcos, Martínez, Patricia, Lluch, Magdalena, Malet, Alfonso, Nam, Young-Hee, Jin, Hyun Jung, Lee, Soo-Keol, Kulalert, Prapasri, Sritipsukho, Paskorn, Pathumanond, Jayanton, Baynova, Krasimira, Labella, Marina, De Aramburu, Teresa, Prados, Manuel, Haanpää, Leena, Aarnio, Jasmin, Nermes, Merja, af Ursin, Piia, Kaljonen, Anne, Bala, Nandana, Bhagwat, Ketaki, Hindley, James, Chapman, Martin, Baalasubramanian, Sivasankar, Besednjak-Kocijančič, Lilijana, SenGupta, Koyel, Antonova, Evgeniya, Kong, Amanda M., Iqbal, Ahmar, Teague, W. Gerald, Trzaskoma, Benjamin, Ortiz, Benjamin, Paknis, Brandee, Iqbal, Amar, Rosen, Karin, Szefler, Stanley, Alblooshi, Afaf, Al-Hammadi, Suleiman, Vega, Arantza, Gutiérrez-Rivas, Raquel, Alonso, Ana Maria, Beitia, Juan Maria, Belén Mateo, Maria, Cárdenas, Remedios, García-Domínguez, Juan Jesús, Pitchon dos Reis, Raquel, Gonçalves Alvim, Cristina, Andrade, Claudia, Reis, Adriana, Ribeiro, Henrique, Panaitescu Bunu, Carmen, Marusciac, Laura, Paralescu, Sorin, Tamas, Paul, Panitescu Bunu, Carmen, Martí Guadaño, Enrique, Escobar Bolaños, Carolina, Martí José, Natalia, Pau Casanovas, Pol, Biarnés Rib, Gemma, Castells, Mariana, de Vicente Jiménez, Talía, Mennini, Maurizio, De Angelis, Papola, Rea, Francesca, Malamisura, Monica, Tambucci, Renato, Dall'Oglio, Luigi, Del Chierico, Federica, Napolitano, Tania, Reddel, Silvia, Vernocchi, Pamela, D'Ambrosio, Angelo, Putignani, Lorenza, Dahdah, Lamia, Banzato, Claudia, Echeverría Zudaire, Luís Angel, Plaza, Ana María, Bosque, Montserrat, Íbero, Marcel, Mazzina, Oscar, Marzano, Valeria, Pecora, Valeria, Koch, Pierluigi, Pecora, Valentina, Valentini, Diletta, Santamaria, Francesca, Mukherjee, Anwesha, Kandhare, Amit, Bodhankar, Subhash, and Universitat Autònoma de Barcelona

Subjects
lcsh:Immunologic diseases. Allergy, Pulmonary and Respiratory Medicine, business.industry, Immunology, MEDLINE, Library science, Meeting Abstracts, Vatican City, Hot topics, Immunology and Allergy, Medicine, lcsh:RC581-607, business
Published
2017

20. Asthma control and disease burden in patients with asthma and allergic comorbidities.

Author

Lee, Lulu K., Obi, Engels, Paknis, Brandee, Kavati, Abhishek, and Chipps, Bradley

Subjects
ASTHMA prevention, ASTHMATICS, QUALITY of life, ADRENOCORTICAL hormones, ADRENERGIC beta agonists, COMORBIDITY
Abstract

Objective: To assess asthma control and associations with health-related quality of life (HRQoL) and economic outcomes among patients with asthma and allergic comorbidities treated with inhaled corticosteroids (ICS) and long-acting beta-agonists (LABA) combination therapy.Methods: Data from the 2011–2013 US National Health and Wellness Survey were used to identify patients with asthma currently treated with ICS and LABA combination therapy (N = 1923). Patients were included if they self-reported a physician diagnosis of asthma and at least one allergic/asthma-related comorbid condition (e.g., nasal allergies, atopic dermatitis). Asthma Control Test scores categorized patients as very poorly (scores ≤ 15; 29.3%), not well (16–19; 25.1%), or well controlled (20–25; 45.7%). Outcomes included HRQoL (SF-36v2; SF-12v2), work productivity and activity impairment, healthcare utilization (HRU), and annual indirect and direct costs. Generalized linear models, controlling for covariates, examined whether outcomes differed by asthma control.Results: Over half of the patients had very poorly or not well-controlled asthma (54.4%). Patients with very poorly controlled versus well-controlled asthma reported significantly greater decreases in HRQoL, greater overall work impairment, and higher HRU (all,p< 0.05). Very poorly controlled patients incurred over double the indirect costs and nearly one and a half times the direct and total costs of well-controlled patients.Conclusions: Increasing level of asthma control was related to improved HRQoL and lower costs. The considerably high prevalence of uncontrolled asthma among patients on ICS and LABA suggests poor treatment adherence or unmet needs in current treatment and may require step-up therapy in appropriate patients according to clinical guidelines. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

21. Real-world treatment patterns and outcomes of omalizumab use in patients with chronic idiopathic urticaria.

Author

Wang, Liya, Ke, Xuehua, Kavati, Abhishek, Wertz, Debra, Huang, Qing, Willey, Vincent J., Stephenson, Judith J., Ortiz, Benjamin, Paknis, Brandee, Bernstein, Jonathan A., and Beck, Lisa A.

Subjects
TREATMENT of urticaria, HEALTH outcome assessment, CHRONIC diseases, URTICARIA, RETROSPECTIVE studies
Abstract

Objective: To examine treatment patterns, treatment response, and demographic and clinical characteristics of patients with chronic idiopathic urticaria (CIU) newly initiated on omalizumab therapy in real-world practice in the US.Methods: This retrospective observational cohort study used US claims data from the HealthCore Integrated Research Database (HIRD®) augmented with medical record data to identify CIU patients newly-treated with omalizumab (≥4 omalizumab claims within 6 months of initial claim; index date = first omalizumab claim date) between March 21, 2014 and October 31, 2015 and with ≥6 months pre- and ≥12 months post-index health plan eligibility. Study outcomes were captured from medical records for up to 12 months pre-index and up to 24 months post-index. Descriptive statistics were reported.Results: This study consisted of 88 patients with a mean (SD) age of 43.4 (± 13.46) years, 68.2% were female, and 36 patients had ≥18 months post-index eligibility. Among 69 patients with documented index dose, 75.4% received omalizumab 300 mg and 69.6% remained on index dose throughout follow-up. For 52 patients with documented index dosing frequency, 96.2% had every 4-week dosing frequency. Among 86 patients with omalizumab documentation, 83.7% reported CIU improvement after omalizumab initiation and 24.4% discontinued omalizumab. For all patients, the proportion using oral corticosteroids (OCS) decreased pre- to post-index (52.3% vs 39.8%). Similar results were observed for patients with ≥18 months post-index eligibility.Conclusions: In this real-world analysis, the majority of patients remained on omalizumab for ≥12 months, and had a positive response. OCS use decreased following omalizumab initiation. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results